EMA validates Daiichi Sankyo-AstraZeneca’s cancer therapy applications
This marks a significant step in the potential approval of the medication for use in the European Union. One application pertains to the treatment of adults with locally
Biopharmaceutical company Celltrion has solidified its presence in the Latin American pharmaceutical market with a series of successful public tender wins in Peru.